Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRAUMATIC ANTERIOR SHOULDER INSTABILITY: A NARRATIVE REVIEW OF CURRENT LITERATURE.

Georgian medical news·2025
Same author

The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of Topography.

Tribology letters·2025
Same author

BENNETT'S FRACTURE: A NARRATIVE REVIEW OF CURRENT LITERATURE.

Georgian medical news·2024
Same author

RECENT TRENDS IN THE USE OF CELL SALVAGER FOR ORTHOPAEDIC TRAUMA AND ELECTIVE SURGERIES-A NARRATIVE REVIEW.

Georgian medical news·2024
Same author

THE PREVALENCE OF SARCOPENIA AND ITS EFFECTS ON OUTCOMES IN POLYTRAUMA.

Georgian medical news·2024
Same author

USE OF TANTALUM CUP IN TOTAL HIP ARTHROPLASTY-A NARRATIVE REVIEW.

Georgian medical news·2024

Related Experiment Video

Updated: Jun 16, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

An optimization of protocol for mixed chimerism induction in mice model.

M Baśkiewicz-Masiuk1, K Grymuła, E Pius

  • 1Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.

Folia Histochemica Et Cytobiologica
|February 19, 2010
PubMed
Summary

Optimizing mixed chimerism induction in mice requires 3 Gy total body irradiation (TBI) and specific blocking antibodies. Reducing TBI or eliminating cyclophosphamide (CP) decreases mixed chimerism rates.

More Related Videos

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates
05:53

Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates

Published on: May 29, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates
05:53

Trans-inner Cell Mass Injection of Embryonic Stem Cells Leads to Higher Chimerism Rates

Published on: May 29, 2018

Area of Science:

  • Immunology
  • Transplantation Biology

Background:

  • Mixed chimerism induction is crucial for transplantation tolerance.
  • Current protocols often involve toxic conditioning regimens.
  • Optimizing these protocols for reduced toxicity is a key research area.

Purpose of the Study:

  • To optimize mixed chimerism induction in mice by reducing conditioning toxicity.
  • To evaluate the necessity of cyclophosphamide (CP) and specific blocking antibodies in this process.

Main Methods:

  • Mice received bone marrow cells and were treated with varying doses of total body irradiation (TBI) and blocking antibodies (anti-CD40L, anti-CD8, anti-NK1.1).
  • Some groups also received post-transplant cyclophosphamide (CP).
  • Mixed chimerism was assessed via flow cytometry, analyzing CD45.1 and CD45.2 expression, alongside CD8 T-cell and NK cell populations.

Main Results:

  • Reduced TBI doses and CP elimination decreased mixed chimerism rates.
  • The highest donor cell percentage was achieved with 3 Gy TBI, CP, and a combination of blocking antibodies.
  • 3 Gy TBI was essential for stable mixed chimerism, though CP was not strictly necessary.

Conclusions:

  • Stable mixed chimerism can be induced with 3 Gy TBI without CP, using specific antibody combinations.
  • This optimized protocol shows potential for reducing toxicity in mixed chimerism induction.
  • Findings may inform future human transplantation strategies, including organ transplantation.